Neuroepithelioma  >>  thrombospondin-1 mimetic (ABT-510)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
thrombospondin-1 mimetic (ABT-510) / AbbVie
NCT00602199: ABT-510 in Treating Patients With Metastatic Melanoma

Completed
2
42
US
ABT-510, immunoenzyme technique, immunohistochemistry staining method, laboratory biomarker analysis, pharmacological study, biopsy
Mayo Clinic, National Cancer Institute (NCI)
Melanoma (Skin)
06/05
06/05

Download Options